| Home |
| |
| • Find out how to outsource your clinical trials to India |
| • Harness the benefits of Indian CRAMS/CSOs within the
current global
pharma business model |
| • Evaluate the implications of moving global R&D off-shore
to India |
| • Examine the influence and input of biotech companies in
the Indian pharma market |
| • Learn about the emerging and innovative business
models for partnerships and collaboration |
| |
| Key Note Speakers |
 |
|
 |
|
 |
|
 |
|
 |
Mr Suhas
Chaudhari
Joint
Commissioner
(Greater Mumbai)
FDA
Maharashtra State |
|
Mr Ranga Iyer
President OPPI and
Managing
Director
Wyeth |
|
Uma Nandan
Misra
Vice President
-Operations &
Site Manager
AstraZeneca Pharma |
|
Mr Ranjit Shahani
Vice Chairman
Managing
Director
and Country President
Novartis |
|
Mr Harjit
Singh
Senior
Development
Manager
Takeda Global Research
and
Development
UK |
|
| |
| |
| Top Level Speakers from |
| Abbott India |
Actis Biologics |
| All India Institute of
Medical Sciences |
Amgen India |
| AstraZeneca Pharma |
Aventis Pharma |
| Cadila Pharmaceuticals |
Dr Reddy's Laboratories |
| Eisai India |
Eli Lilly &Co. |
| Evolva Biotech |
FDA Maharashtra State |
| GlaxoSmithKline
Pharmaceuticals |
Institute of Clinical
Research India |
| Nishith Desai Associates |
Novartis |
| Nycomed Pharma USA |
Pfizer |
| Sandoz |
Takeda Global Research
and Development |
| USV |
Wockhardt |
| Wyeth |
Zydus Cadila |
|
| |
| Which industry sectors should attend? |
• Pharmaceutical Companies |
• Biotech Companies |
• CROs and CMOs |
• Pharmaceutical Manufacturers |
• Research Laboratories and Institutes |
• Business Consulting Firms |
• Government Institutions and Regulators |
• Private Equity Funds |
• Venture Capitalists |
| |
| |
| Who will be there? |
The Global Pharmaceuticals conference has been
developed with the following executives in mind: |
| • CXOs |
| • Project Directors |
| |
| |
